Erschienen in:
13.12.2023 | Original Article
Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma
verfasst von:
Manuel Pedrero Prieto, David Gorriz Romero, Elisa Gómez Roch, Francisco-Carlos Pérez Miralles, Bonaventura Casanova Estruch
Erschienen in:
Neurological Sciences
|
Ausgabe 5/2024
Einloggen, um Zugang zu erhalten
Abstract
Immune checkpoint inhibitors (ICIs) are a pharmacological group increasingly used in Oncology and Hematology. These treatments can lead to autoimmune complications, with neurological conditions, especially central nervous system (CNS) involvement, being rare. We describe a case of seropositive neuromyelitis optica in a patient with locally advanced lung adenocarcinoma treated with Atezolizumab.